Karrenbauer, Virginija Danylaité
Bedri, Sahl Khalid
Hillert, Jan
Manouchehrinia, Ali
Funding for this research was provided by:
Biogen
Karolinska Institute
Article History
Received: 7 March 2021
Accepted: 7 July 2021
First Online: 22 July 2021
Competing interests
: SKB and AM report no conflicts of interest. JH received honoraria for serving on advisory boards for Biogen, Sanofi-Genzyme and Novartis and speaker’s fees from Biogen, Merck-Serono, Bayer-Schering, Teva and Sanofi-Genzyme. He has served as P.I. for projects sponsored by, or received unrestricted research support from, Biogen, Merck-Serono, TEVA, Novartis, Sanofi-Genzyme and Bayer-Schering. VDK has received financial support from Stockholm County Council (grant ALF 20160457); Biogen (recipient of grant and scholarship, PI for project sponsored by); Novartis (Scientific Advisory board member, recipient of scholarship and lecture honoraria); Merc (Scientific Advisory Board member, recipient of lecture honoraria), Neuro Vigil (Scientific Advisory Board member).